Literature DB >> 7851011

Tumour necrosis factor-alpha (TNF-alpha) synthesis is associated with the skin and peripheral nerve pathology of leprosy reversal reactions.

S Khanolkar-Young1, N Rayment, P M Brickell, D R Katz, S Vinayakumar, M J Colston, D N Lockwood.   

Abstract

Leprosy may be complicated by episodes of increased cell-mediated immunity towards Mycobacterium leprae (reversal reactions) which result in severe local immunopathology in skin lesions and peripheral nerves. Using in situ hybridization and MoAb techniques we have demonstrated TNF-alpha mRNA and TNF-alpha protein in macrophages infiltrating leprosy skin and peripheral nerve. Levels of TNF-alpha mRNA are significantly increased in reactional skin and nerve, particularly in borderline tuberculoid patients. TNF-alpha mRNA and TNF-alpha protein levels are higher in reactional nerves then reactional skin. In both reactional skin and nerve TNF-alpha mRNA is more abundant than TNF-alpha protein; this may reflect the rapid turnover of TNF-alpha protein in an immunologically dynamic situation, such as is seen in reversal reaction. Our findings emphasize the importance of documenting both mRNA and protein production when assessing the role of cytokines in pathology. The leprosy reversal reaction may be regarded as a useful model of tissue immunopathology in which TNF-alpha is generated as part of the host response to infection, but also produces local tissue damage.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7851011      PMCID: PMC1534301          DOI: 10.1111/j.1365-2249.1995.tb05532.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

1.  Therapeutic trials in leprosy using serial biopsies.

Authors:  D S RIDLEY
Journal:  Lepr Rev       Date:  1958-01       Impact factor: 0.537

2.  Cytokine patterns of immunologically mediated tissue damage.

Authors:  M Yamamura; X H Wang; J D Ohmen; K Uyemura; T H Rea; B R Bloom; R L Modlin
Journal:  J Immunol       Date:  1992-08-15       Impact factor: 5.422

3.  Classification of leprosy according to immunity. A five-group system.

Authors:  D S Ridley; W H Jopling
Journal:  Int J Lepr Other Mycobact Dis       Date:  1966 Jul-Sep

4.  Expression of adhesion molecules in leprosy lesions.

Authors:  L Sullivan; S Sano; C Pirmez; P Salgame; C Mueller; F Hofman; K Uyemura; T H Rea; B R Bloom; R L Modlin
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

Review 5.  Cytokines and the Koch phenomenon.

Authors:  G A Rook; R al Attiyah
Journal:  Tubercle       Date:  1991-03

6.  Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro.

Authors:  K W Selmaj; C S Raine
Journal:  Ann Neurol       Date:  1988-04       Impact factor: 10.422

7.  Binding of antibodies raised against tumour necrosis factor alpha (TNF alpha) to blood vessels and macrophages in inflamed synovial tissue.

Authors:  L S Wilkinson; J C Edwards
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

8.  Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex.

Authors:  L E Bermudez; L S Young
Journal:  J Immunol       Date:  1988-05-01       Impact factor: 5.422

9.  The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection.

Authors:  V Kindler; A P Sappino; G E Grau; P F Piguet; P Vassalli
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

Review 10.  Interferon-gamma.

Authors:  E De Maeyer; J De Maeyer-Guignard
Journal:  Curr Opin Immunol       Date:  1992-06       Impact factor: 7.486

View more
  27 in total

1.  Inhibition of apoptosis by ionomycin and zinc in peripheral blood mononuclear cells (PBMC) of leprosy patients.

Authors:  A Gupta; V K Sharma; H Vohra; N K Ganguly
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

2.  Reactions following completion of 1 and 2 year multidrug therapy (MDT).

Authors:  Ma Victoria F Balagon; Robert H Gelber; Rodolfo M Abalos; Roland V Cellona
Journal:  Am J Trop Med Hyg       Date:  2010-09       Impact factor: 2.345

3.  Soluble tumor necrosis factor alpha receptors in sera from leprosy patients.

Authors:  M E Munk; P Anding; A P Schettini; M G Cunha; S H Kaufmann
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

Review 4.  Mycobacterium leprae-host-cell interactions and genetic determinants in leprosy: an overview.

Authors:  Roberta Olmo Pinheiro; Jorgenilce de Souza Salles; Euzenir Nunes Sarno; Elizabeth Pereira Sampaio
Journal:  Future Microbiol       Date:  2011-02       Impact factor: 3.165

5.  Pentoxifylline decreases in vivo and in vitro tumour necrosis factor-alpha (TNF-alpha) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL).

Authors:  E P Sampaio; M O Moraes; J A Nery; A R Santos; H C Matos; E N Sarno
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

Review 6.  The armadillo as a model for peripheral neuropathy in leprosy.

Authors:  Richard W Truman; Gigi J Ebenezer; Maria T Pena; Rahul Sharma; Gayathriy Balamayooran; Thomas H Gillingwater; David M Scollard; Justin C McArthur; Anura Rambukkana
Journal:  ILAR J       Date:  2014

7.  High levels of inflammatory cytokines are associated with poor clinical response to steroid treatment and recurrent episodes of type 1 reactions in leprosy.

Authors:  R Manandhar; N Shrestha; C R Butlin; P W Roche
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

8.  Immunohistochemical analysis of cellular infiltrate and gamma interferon, interleukin-12, and inducible nitric oxide synthase expression in leprosy type 1 (reversal) reactions before and during prednisolone treatment.

Authors:  D Little; S Khanolkar-Young; A Coulthart; S Suneetha; D N Lockwood
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

9.  IgG1 antimycobacterial antibodies can reverse the inhibitory effect of pentoxifylline on tumour necrosis factor alpha (TNF-alpha) secreted by mycobacterial antigen-stimulated adherent cells.

Authors:  S M Thakurdas; Z Hasan; R Hussain
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

10.  Granuloma necrosis during Mycobacterium avium infection does not require tumor necrosis factor.

Authors:  Manuela Flórido; Rui Appelberg
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.